Cyclostreptin binds covalently to microtubule pores and lumenal taxoid binding sites

被引:118
作者
Buey, Ruben M.
Calvo, Enrique
Barasoain, Isabel
Pineda, Oriol
Edler, Michael C.
Matesanz, Ruth
Cerezo, Gemma
Vanderwal, Christopher D.
Day, Billy W.
Sorensen, Erik J.
Lopez, Juan Antonio
Andreu, Jose Manuel
Hamel, Ernest
Diaz, J. Fernando
机构
[1] CSIC, Ctr Invest Biol, E-28040 Madrid, Spain
[2] Ctr Nacl Invest Cardiovasc, Unidad Proteom, Madrid 28029, Spain
[3] Univ Barcelona, Fac Quim, Dept Quim Organ, E-08028 Barcelona, Spain
[4] NCI, Toxicol & Pharmacol Branch, Dev Therapeut Program, Div Canc Treatment & Diag,NIH, Frederick, MD 21702 USA
[5] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA
[6] PharmaMar SA, Colmenar Viejo 28770, Spain
[7] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA
[8] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15261 USA
[9] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA
关键词
D O I
10.1038/nchembio853
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cyclostreptin ( 1), a natural product from Streptomyces sp. 9885, irreversibly stabilizes cellular microtubules, causes cell cycle arrest, evades drug resistance mediated by P- glycoprotein in a tumor cell line and potently inhibits paclitaxel binding to microtubules, yet it only weakly induces tubulin assembly. In trying to understand this paradox, we observed irreversible binding of synthetic cyclostreptin to tubulin. This results from formation of covalent crosslinks to beta- tubulin in cellular microtubules and microtubules formed from purified tubulin in a 1: 1 total stoichiometry distributed between Thr220 ( at the outer surface of a pore in the microtubule wall) and Asn228 ( at the lumenal paclitaxel site). Unpolymerized tubulin was only labeled at Thr220. Thus, the pore region of beta- tubulin is an undescribed binding site that ( i) elucidates the mechanism by which taxoid-site compounds reach the kinetically unfavorable lumenal site and ( ii) explains how taxoid-site drugs induce microtubule formation from dimeric and oligomeric tubulin.
引用
收藏
页码:117 / 125
页数:9
相关论文
共 31 条
[11]   Fast kinetics of taxol binding to microtubules -: Effects of solution variables and microtubule-associated proteins [J].
Díaz, JF ;
Barasoain, I ;
Andreu, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (10) :8407-8419
[12]   ASSEMBLY OF PURIFIED GDP TUBULIN INTO MICROTUBULES INDUCED BY TAXOL AND TAXOTERE - REVERSIBILITY, LIGAND STOICHIOMETRY, AND COMPETITION [J].
DIAZ, JF ;
ANDREU, JM .
BIOCHEMISTRY, 1993, 32 (11) :2747-2755
[13]   THERMODYNAMICS OF LIGAND-INDUCED ASSEMBLY OF TUBULIN [J].
DIAZ, JF ;
MENENDEZ, M ;
ANDREU, JM .
BIOCHEMISTRY, 1993, 32 (38) :10067-10077
[14]   Cyclostreptin (FR182877), an antitumor tubulin-polymerizing agent deficient in enhancing tubulin assembly despite its high affinity for the taxoid site [J].
Edler, MC ;
Buey, RM ;
Gussio, R ;
Marcus, AI ;
Vanderwal, CD ;
Sorensen, EJ ;
Díaz, JF ;
Giannakakou, P ;
Ernest, H .
BIOCHEMISTRY, 2005, 44 (34) :11525-11538
[15]   Drug-protein adducts: An industry perspective on minimizing the potential for drug bioactivation in drug discovery and development [J].
Evans, DC ;
Watt, AP ;
Nicoll-Griffith, DA ;
Baillie, TA .
CHEMICAL RESEARCH IN TOXICOLOGY, 2004, 17 (01) :3-16
[16]   A common pharmacophore for epothilone and taxanes: Molecular basis for drug resistance conferred by tubulin mutations in human cancer cells [J].
Giannakakou, P ;
Gussio, R ;
Nogales, E ;
Downing, KH ;
Zaharevitz, D ;
Bollbuck, B ;
Poy, G ;
Sackett, D ;
Nicolaou, KC ;
Fojo, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) :2904-2909
[17]   Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization [J].
Giannakakou, P ;
Sackett, DL ;
Kang, YK ;
Zhan, ZR ;
Buters, JTM ;
Fojo, T ;
Poruchynsky, MS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (27) :17118-17125
[18]  
HADVARY P, 1991, J BIOL CHEM, V266, P2021
[19]   Orlistat: A review of its use in the management of obesity [J].
Henness, Sheridan ;
Perry, Caroline M. .
DRUGS, 2006, 66 (12) :1625-1656
[20]   Microtubules as a target for anticancer drugs [J].
Jordan, MA ;
Wilson, L .
NATURE REVIEWS CANCER, 2004, 4 (04) :253-265